Maxine Gowen, Director at Aceragen, Inc. (ACGN), sold 51 shares at $0.51 ($26) on 2023-08-10, disclosed to the SEC on 2023-08-11.
Open-market sale of $26 ACGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TRVN | BUY | 2016-11-09 | $103K | — | Filing → |
| IDRA | BUY | 2016-10-05 | $11K | — | Filing → |
| TRVN | BUY | 2016-05-31 | $257K | — | Filing → |